The interventional radiology market size has grown rapidly in recent years. It will grow from $29.98 billion in 2025 to $33.94 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to rising prevalence of chronic vascular diseases, increasing adoption of minimally invasive treatment approaches, expansion of hospital imaging infrastructure, growing use of catheter-based interventions, improvements in diagnostic imaging technologies.
The interventional radiology market size is expected to see rapid growth in the next few years. It will grow to $54.31 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing demand for precision oncology interventions, rising investments in advanced imaging systems, expansion of interventional radiology training programs, growing use of image-guided therapies, increasing preference for outpatient interventional procedures. Major trends in the forecast period include increasing adoption of image-guided minimally invasive procedures, rising integration of advanced imaging modalities, growing demand for precision-based interventional therapies, expansion of hybrid operating room installations, enhanced focus on procedure accuracy and patient outcomes.
The rising prevalence of cancer is anticipated to propel the growth of the interventional radiology market in the upcoming years. Cancer is a significant global health issue and ranks as the second leading cause of death in the United States. Interventional radiology employs various techniques, including ablation, embolization, and irreversible electroporation (IRE), to treat cancer and cardiovascular conditions. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that the number of diagnosed cancer cases in the country rose from 160,570 in 2022 to 164,694 in 2023, indicating a substantial increase over the year. This trend underscores the growing incidence of cancer in Australia. Therefore, the increasing prevalence of cancer is driving the growth of the interventional radiology market.
Major companies operating in the interventional radiology market are introducing advanced technological solutions such as the AI-powered Viz Radiology Suite to enhance profitability and competitive positioning. The AI-powered Viz Radiology Suite is an advanced radiology workflow platform developed by Viz.ai that applies artificial intelligence to analyze medical images and support clinical decision-making. For example, in October 2023, GE HealthCare, a U.S.-based medical technology company, obtained FDA 510(k) clearance for its Allia IGS Pulse system. This next-generation image-guided interventional platform features an AI-enabled AutoRight PLUS image chain that automatically adjusts seven imaging parameters in real time. The technology enhances image quality, improves visualization, and helps manage radiation dose during interventional radiology procedures, supporting faster and more efficient clinical decision-making.
In January 2023, GE Healthcare Technologies Inc., a US-based medical technology company, acquired IMACTIS for an undisclosed amount. Motivated by the opportunity to expand its interventional radiology business, integrate complementary technologies, and enhance image-guided therapeutic solutions, the acquisition of IMACTIS, a France-based medical technology company, aligns with GE Healthcare's commitment to advancing its capabilities for the benefit of clients and patients.
Major companies operating in the interventional radiology market are Carestream Health Inc., Siemens Aktiengesellschaft, Koninklijke Philips N.V., General Electric Company, Hitachi Ltd., Canon Medical Systems Corporation, Shimadzu Corporation, FUJIFILM Holdings Corporation, Hologic Inc., Agfa-Gevaert N.V., Esaote S.p.A., Samsung Medison Co. Ltd., Cook Group Incorporated, Medtronic plc, Abbott Laboratories, AngioDynamics Inc., B. Braun Melsungen AG, C. R. Bard Inc., Terumo Corporation, Merit Medical Systems Inc., Penumbra Inc., BTG International Ltd., Guerbet Group, Medrad Inc., MicroPort Scientific Corporation, Neusoft Medical Systems Co. Ltd.
North America was the largest region in the interventional radiology global market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional radiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the interventional radiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the interventional radiology market by increasing costs of imported imaging systems, catheters, contrast agents, and interventional accessories used in angiography, fluoroscopy, and biopsy procedures. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on advanced imported imaging equipment, while Asia-Pacific faces cost pressures on system procurement. These tariffs are raising capital expenditure and delaying technology upgrades. However, they are also encouraging localized manufacturing, regional supplier partnerships, and domestic innovation in imaging and interventional device production.
The interventional radiology market research report is one of a series of new reports that provides interventional radiology market statistics, including interventional radiology industry global market size, regional shares, competitors with a interventional radiology market share, detailed interventional radiology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional radiology industry. This interventional radiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Interventional radiology, a specialized field within radiology, employs medical imaging techniques to guide minimally invasive surgical procedures for both diagnostic and therapeutic purposes.
The primary products in the interventional radiology market encompass MRI, ultrasound imaging, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, and various others. MRI interventional radiology devices excel in producing detailed images of organs and tissues within the body. The range of procedures performed includes angioplasty, angiography, biopsy and drainage, embolization, thrombolysis, vertebroplasty, nephrostomy, and more. These procedures find application across diverse medical specialties such as cardiology, urology and nephrology, oncology, gastroenterology, and various others.
The interventional radiology market consists of sales of atherectomy systems, cancer therapies, and balloon catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The interventional radiology market size is expected to see rapid growth in the next few years. It will grow to $54.31 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing demand for precision oncology interventions, rising investments in advanced imaging systems, expansion of interventional radiology training programs, growing use of image-guided therapies, increasing preference for outpatient interventional procedures. Major trends in the forecast period include increasing adoption of image-guided minimally invasive procedures, rising integration of advanced imaging modalities, growing demand for precision-based interventional therapies, expansion of hybrid operating room installations, enhanced focus on procedure accuracy and patient outcomes.
The rising prevalence of cancer is anticipated to propel the growth of the interventional radiology market in the upcoming years. Cancer is a significant global health issue and ranks as the second leading cause of death in the United States. Interventional radiology employs various techniques, including ablation, embolization, and irreversible electroporation (IRE), to treat cancer and cardiovascular conditions. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that the number of diagnosed cancer cases in the country rose from 160,570 in 2022 to 164,694 in 2023, indicating a substantial increase over the year. This trend underscores the growing incidence of cancer in Australia. Therefore, the increasing prevalence of cancer is driving the growth of the interventional radiology market.
Major companies operating in the interventional radiology market are introducing advanced technological solutions such as the AI-powered Viz Radiology Suite to enhance profitability and competitive positioning. The AI-powered Viz Radiology Suite is an advanced radiology workflow platform developed by Viz.ai that applies artificial intelligence to analyze medical images and support clinical decision-making. For example, in October 2023, GE HealthCare, a U.S.-based medical technology company, obtained FDA 510(k) clearance for its Allia IGS Pulse system. This next-generation image-guided interventional platform features an AI-enabled AutoRight PLUS image chain that automatically adjusts seven imaging parameters in real time. The technology enhances image quality, improves visualization, and helps manage radiation dose during interventional radiology procedures, supporting faster and more efficient clinical decision-making.
In January 2023, GE Healthcare Technologies Inc., a US-based medical technology company, acquired IMACTIS for an undisclosed amount. Motivated by the opportunity to expand its interventional radiology business, integrate complementary technologies, and enhance image-guided therapeutic solutions, the acquisition of IMACTIS, a France-based medical technology company, aligns with GE Healthcare's commitment to advancing its capabilities for the benefit of clients and patients.
Major companies operating in the interventional radiology market are Carestream Health Inc., Siemens Aktiengesellschaft, Koninklijke Philips N.V., General Electric Company, Hitachi Ltd., Canon Medical Systems Corporation, Shimadzu Corporation, FUJIFILM Holdings Corporation, Hologic Inc., Agfa-Gevaert N.V., Esaote S.p.A., Samsung Medison Co. Ltd., Cook Group Incorporated, Medtronic plc, Abbott Laboratories, AngioDynamics Inc., B. Braun Melsungen AG, C. R. Bard Inc., Terumo Corporation, Merit Medical Systems Inc., Penumbra Inc., BTG International Ltd., Guerbet Group, Medrad Inc., MicroPort Scientific Corporation, Neusoft Medical Systems Co. Ltd.
North America was the largest region in the interventional radiology global market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional radiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the interventional radiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the interventional radiology market by increasing costs of imported imaging systems, catheters, contrast agents, and interventional accessories used in angiography, fluoroscopy, and biopsy procedures. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on advanced imported imaging equipment, while Asia-Pacific faces cost pressures on system procurement. These tariffs are raising capital expenditure and delaying technology upgrades. However, they are also encouraging localized manufacturing, regional supplier partnerships, and domestic innovation in imaging and interventional device production.
The interventional radiology market research report is one of a series of new reports that provides interventional radiology market statistics, including interventional radiology industry global market size, regional shares, competitors with a interventional radiology market share, detailed interventional radiology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional radiology industry. This interventional radiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Interventional radiology, a specialized field within radiology, employs medical imaging techniques to guide minimally invasive surgical procedures for both diagnostic and therapeutic purposes.
The primary products in the interventional radiology market encompass MRI, ultrasound imaging, CT scanners, angiography systems, fluoroscopy systems, biopsy devices, and various others. MRI interventional radiology devices excel in producing detailed images of organs and tissues within the body. The range of procedures performed includes angioplasty, angiography, biopsy and drainage, embolization, thrombolysis, vertebroplasty, nephrostomy, and more. These procedures find application across diverse medical specialties such as cardiology, urology and nephrology, oncology, gastroenterology, and various others.
The interventional radiology market consists of sales of atherectomy systems, cancer therapies, and balloon catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Interventional Radiology Market Characteristics
3. Interventional Radiology Market Supply Chain Analysis
4. Global Interventional Radiology Market Trends and Strategies
5. Interventional Radiology Market Analysis of End Use Industries
7. Global Interventional Radiology Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Interventional Radiology Total Addressable Market (TAM) Analysis for the Market
9. Interventional Radiology Market Segmentation
10. Interventional Radiology Market Regional and Country Analysis
11. Asia-Pacific Interventional Radiology Market
12. China Interventional Radiology Market
13. India Interventional Radiology Market
14. Japan Interventional Radiology Market
15. Australia Interventional Radiology Market
16. Indonesia Interventional Radiology Market
17. South Korea Interventional Radiology Market
18. Taiwan Interventional Radiology Market
19. South East Asia Interventional Radiology Market
20. Western Europe Interventional Radiology Market
21. UK Interventional Radiology Market
22. Germany Interventional Radiology Market
23. France Interventional Radiology Market
24. Italy Interventional Radiology Market
25. Spain Interventional Radiology Market
26. Eastern Europe Interventional Radiology Market
27. Russia Interventional Radiology Market
28. North America Interventional Radiology Market
29. USA Interventional Radiology Market
30. Canada Interventional Radiology Market
31. South America Interventional Radiology Market
32. Brazil Interventional Radiology Market
33. Middle East Interventional Radiology Market
34. Africa Interventional Radiology Market
36. Interventional Radiology Market Competitive Landscape and Company Profiles
37. Interventional Radiology Market Other Major and Innovative Companies
40. Interventional Radiology Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Interventional Radiology Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses interventional radiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for interventional radiology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional radiology market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Ultrasound Imaging; Angiography Systems; Fluoroscopy Systems; Biopsy Devices2) By Procedure: Angioplasty; Angiography; Biopsy And Drainage; Embolization; Thrombolysis; Vertebroplasty; Nephrostomy
3) By Application: Oncology; Urology And Nephrology; Gastroenterology
Subsegments:
1) By Ultrasound Imaging: Portable Ultrasound Systems; Diagnostic Ultrasound Systems; 3D/4D Ultrasound Systems2) By Angiography Systems: Digital Subtraction Angiography (DSA) Systems; Mobile Angiography Systems; Hybrid Angiography Systems
3) By Fluoroscopy Systems: Fixed Fluoroscopy Systems; Mobile Fluoroscopy Systems; C-arm Fluoroscopy Systems
4) By Biopsy Devices: Needle Biopsy Devices; Vacuum-Assisted Biopsy Devices; Stereotactic Biopsy Devices
Companies Mentioned: Carestream Health Inc.; Siemens Aktiengesellschaft; Koninklijke Philips N.V.; General Electric Company; Hitachi Ltd.; Canon Medical Systems Corporation; Shimadzu Corporation; FUJIFILM Holdings Corporation; Hologic Inc.; Agfa-Gevaert N.V.; Esaote S.p.A.; Samsung Medison Co. Ltd.; Cook Group Incorporated; Medtronic plc; Abbott Laboratories; AngioDynamics Inc.; B. Braun Melsungen AG; C. R. Bard Inc.; Terumo Corporation; Merit Medical Systems Inc.; Penumbra Inc.; BTG International Ltd.; Guerbet Group; Medrad Inc.; MicroPort Scientific Corporation; Neusoft Medical Systems Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Interventional Radiology market report include:- Carestream Health Inc.
- Siemens Aktiengesellschaft
- Koninklijke Philips N.V.
- General Electric Company
- Hitachi Ltd.
- Canon Medical Systems Corporation
- Shimadzu Corporation
- FUJIFILM Holdings Corporation
- Hologic Inc.
- Agfa-Gevaert N.V.
- Esaote S.p.A.
- Samsung Medison Co. Ltd.
- Cook Group Incorporated
- Medtronic plc
- Abbott Laboratories
- AngioDynamics Inc.
- B. Braun Melsungen AG
- C. R. Bard Inc.
- Terumo Corporation
- Merit Medical Systems Inc.
- Penumbra Inc.
- BTG International Ltd.
- Guerbet Group
- Medrad Inc.
- MicroPort Scientific Corporation
- Neusoft Medical Systems Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 33.94 Billion |
| Forecasted Market Value ( USD | $ 54.31 Billion |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
